The pharmaceutical industry is bracing for a significant financial blow. Analysts forecast costs of between $13 billion and $19 billion following a new transatlantic trade deal. This deal will subject branded medicines to a hefty 15% tariff.
Trade Tariffs and Their Impact on Pharmaceuticals
About healthmatters
0 Comments